title: All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alpha in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines.
authors.forename: D
authors.initials: D
authors.lastname: Russo
authors.forename: G
authors.initials: G
authors.lastname: Tell
authors.forename: L
authors.initials: L
authors.lastname: Marin
authors.forename: M
authors.initials: M
authors.lastname: Tiribelli
authors.forename: M A
authors.initials: MA
authors.lastname: Santucci
authors.forename: C
authors.initials: C
authors.lastname: Pucillo
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D004359:Drug Therapy, Combination; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D016898:Interferon-alpha / Q000187:drug effects* / Q000494:pharmacology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D051379:Mice; D015513:Oncogene Proteins; D010677:Philadelphia Chromosome; D014162:Transfection; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D016898:Interferon-alpha; D015513:Oncogene Proteins; D014212:Tretinoin; D016044:Fusion Proteins, bcr-abl